Infectious Diseases Related Content

Y-h. Taguchi, Professor at Chuo University in Japan, reveals how to compete with COVID-19 by using a computer.

Ann Matthysse, Department of Biology, University of North Carolina, explores what exactly a virus is, with a specific focus on RNA viruses and SARS-CoV-2.

According to the latest data, UK COVID infections are at their highest since May, 2020 - with levels especially high in school-aged children.

Pfizer has announced that its antiviral pill, PAXLOVID, is 89% effective in reducing COVID-19 hospitalisation and death.

Fluvoxamine, a cheap repurposed drug, can cut COVID-19 hospitalisations by up to 30%, according to a new study.

Gill Nye, Executive Head of HR at Cantium Business Solutions, explores the effect long covid will have on the workplace, with a particular focus on occupational health provision.

Find out everything you need to know about the UK Government's COVID-19 vaccination programme as the NHS begins to rollout booster jabs.

According to a new study, a third of leukaemia patients fail to generate an antibody response following two COVID-19 vaccine doses.

According to a new study, there is no risk of pregnancy loss associated with COVID-19 vaccinations.

Captain Casey Barton Behravesh of the U.S. Public Health Service, and Director of the CDC One Health Office highlights the CDC’s efforts to nationally and internationally prevent zoonotic diseases.

With a changing climate, animal, insect, and plant species will either adapt or die under new environmental and climate conditions - this brings new challenges in the study of vector-borne infectious diseases.

Andrew Metcalfe, Director of Intelligent Infection Control Services Limited, LumiBio, explores the lessons learned in infection prevention and control.

Lauren Matelski, Jeremy MacMahon, and Pamela J. Lein from the University of California, Davis, weigh the risks associated with COVID-19 vaccines versus the benefits.

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, offers preliminary context about the impact of the COVID-19 pandemic in most African countries, starting with lessons to be learned from previous outbreaks.

Luke S. P. Moore, Infectious Diseases Physician and Clinical Microbiologist on behalf of the Healthcare Infection Society, directs our thoughts to optimising our control of infections and looks forward to the post-pandemic period.

Dr Quinton Fivelman, PhD, Chief Scientific Officer at London Medical Laboratory, reveals that antibody levels for the double-jabbed are now waning. He asks was the UK Government unwise to relax most COVID precautions in July?.

Double vaccinated adults are 49% less likely to have Long COVID if they were to contract COVID-19, according to a new study.

Five new COVID-19 research projects will study the durability of vaccine responses, low responses linked with health conditions and the effect of booster shots.

A new clinical trial will investigate whether a third COVID-19 vaccine dose gives a stronger immune response for people with weakened immune systems.

Dr Deborah Lee from Dr Fox Online Pharmacy, reveals the risks of using alcohol-based hand sanitiser.